Viewing Study NCT05618457

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-02-28 @ 7:11 PM
Study NCT ID: NCT05618457
Status: RECRUITING
Last Update Posted: 2024-03-01
First Post: 2022-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration
Sponsor: Hadassah Medical Organization
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aminoglycoside Dosing Based on PK/PD Characteristics View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Aminoglycosides View
None Minimal Inhibitory Concentration (MIC) View
None Gram negative View
None PK/PD View
None Peak concentration (Cmax) View